| 摘要 |
This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions. |
| 申请人 |
ABBOTT LABORATORIES |
发明人 |
LIU, DACHUN;BETEBENNER, DAVID, A.;PRATT, JOHN, K.;DEGOEY, DAVID, A.;DONNER, PAMELA, L.;FLENTGE, CHARLES, A.;HUTCHINSON, DOUGLAS, K.;KATI, WARREN, M.;KRUEGER, ALLAN, C.;LONGENECKER, KENTON L.;MARING, CLARENCE, J.;RANDOLPH, JOHN, T.;ROCKWAY, TODD, W.;TUFANO, MICHAEL, D.;WAGNER, ROLF |
